Items where Author is "Moseley, P"

Journal article

ABDEL-FATAH, T.M.A., REES, R.C., POCKLEY, A.G., MOSELEY, P., BALL, G.R., CHAN, S.Y.T., ELLIS, I.O. and MILES, A.K., 2017. The localisation of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2. Oncotarget, 8, pp. 112245-112257. ISSN 1949-2553

ALBARAKATI, N., ABDEL-FATAH, T.M.A., DOHERTY, R., RUSSELL, R., AGARWAL, D., MOSELEY, P., PERRY, C., ARORA, A., ALSUBHI, N., SEEDHOUSE, C., RAKHA, E.A., GREEN, A., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O. and MADHUSUDAN, S., 2015. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular Oncology, 9 (1), pp. 204-217. ISSN 1574-7891

ABDEL-FATAH, T.M.A., ARORA, A., MOSELEY, P., COVENEY, C., PERRY, C., JOHNSON, K., KENT, C., BALL, G., CHAN, S. and MADHUSUDAN, S., 2014. ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers. BBA Clinical, 2, pp. 10-17. ISSN 2214-6474

ABDEL-FATAH, T., ARORA, A., AGARWAL, D., MOSELEY, P., PERRY, C., THOMPSON, N., GREEN, A.R., RAKHA, E., CHAN, S., BALL, G., ELLIS, I.O. and MADHUSUDAN, S., 2014. Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers. Breast Cancer Research and Treatment, 146 (2), pp. 309-320. ISSN 0167-6806

ABDEL-FATAH, T., ARORA, A., AGARWAL, D., MOSELEY, P., PERRY, C., THOMPSON, N., GREEN, A.R., RAKHA, E., CHAN, S., BALL, G., ELLIS, I.O. and MADHUSUDAN, S., 2014. Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers. Breast Cancer Research and Treatment, 146 (2), pp. 309-320. ISSN 0167-6806

ABDEL-FATAH, T.M.A., RUSSELL, R., AGARWAL, D., MOSELEY, P., ABAYOMI, M., PERRY, C., ALBARAKATI, N., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O. and MADHUSUDAN, S., 2014. DNA polymerase B deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts. Molecular Oncology, 8 (3), pp. 520-532. ISSN 1574-7891

ABDEL-FATAH, T.M.A., RUSSELL, R., ALBARAKATI, N., MALONEY, D.J., DORJSUREN, D., RUEDA, O.M., MOSELEY, P., MOHAN, V., SUN, H., ABBOTTS, R., MUKHERJEE, A., AGARWAL, D., ILLUZZI, J.L., JADHAV, A., SIMEONOV, A., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O., WILSON, D.M. and MADHUSUDAN, S., 2014. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer. Molecular Oncology, 8 (7), pp. 1326-1338. ISSN 1574-7891

ABDEL-FATAH, T.M.A., PERRY, C., DICKINSON, P., BALL, G., MOSELEY, P., MADHUSUDAN, S., ELLIS, I.O. and CHAN, S.Y.T., 2013. Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings. Annals of Oncology, 24 (11), pp. 2801-2807. ISSN 1569-8041

ABDEL-FATAH, T.M.A., ALBARAKATI, N., BOWELL, L., AGARWAL, D., MOSELEY, P., HAWKES, C., BALL, G., CHAN, S., ELLIS, I.O. and MADHUSUDAN, S., 2013. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy. Breast Cancer Research and Treatment, 142 (3), pp. 515-527. ISSN 0167-6806